• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺切除术后验证修订的胸段心脏风险指数

Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection.

作者信息

Thomas Daniel C, Blasberg Justin D, Arnold Brian N, Rosen Joshua E, Salazar Michelle C, Detterbeck Frank C, Boffa Daniel J, Kim Anthony W

机构信息

Section of Thoracic Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.

Division of Thoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California.

出版信息

Ann Thorac Surg. 2017 Aug;104(2):389-394. doi: 10.1016/j.athoracsur.2017.02.006. Epub 2017 May 9.

DOI:10.1016/j.athoracsur.2017.02.006
PMID:28499655
Abstract

BACKGROUND

The Thoracic Revised Cardiac Index (ThRCRI) is a tool that differentiates patients who may proceed to lung resection (classes A or B) from those who should receive additional cardiac evaluation (classes C or D). This study aims to describe the ability of the ThRCRI to stratify patients based on major cardiac complication rates using a large multi-institutional dataset.

METHODS

Patients undergoing lobectomy or pneumonectomy were identified in the American College of Surgeons National Surgical Quality Improvement Program dataset from 2005 to 2012. Patients were grouped into 4 risk classes based on a summary score of preoperative risk factors: ischemic heart disease, cerebrovascular disease, renal comorbidity, and pneumonectomy. The primary outcome was the incidence of perioperative major cardiac complication in each of the 4 risk classes.

RESULTS

Of the 4,625 patients identified, the majority underwent surgery for malignant disease (78%) and had an open procedure (70%). Among ThRCRI risk factors, 9% of patients had ischemic heart disease, 7% had cerebrovascular disease, 2% had renal comorbidity, and 6% underwent pneumonectomy. Incidence of cardiac complication in all patients was 2%. Incidence of cardiac complication within risk classes A, B, C, and D were 1%, 3%, 9%, and 4%, respectively (p < 0.01).

CONCLUSIONS

Using a large multi-institutional dataset, the ThRCRI can differentiate patients at higher risk for cardiac complication following lung resection (classes C and D) and can be a useful preoperative instrument. The ThRCRI may allow for identifying patients who would benefit from additional cardiac evaluation.

摘要

背景

胸段修订心脏指数(ThRCRI)是一种可区分可能进行肺切除术的患者(A类或B类)与应接受额外心脏评估的患者(C类或D类)的工具。本研究旨在利用一个大型多机构数据集描述ThRCRI根据主要心脏并发症发生率对患者进行分层的能力。

方法

在美国外科医师学会国家外科质量改进计划数据集中识别2005年至2012年期间接受肺叶切除术或全肺切除术的患者。根据术前危险因素的综合评分将患者分为4个风险类别:缺血性心脏病、脑血管疾病、肾脏合并症和全肺切除术。主要结局是4个风险类别中每一类围手术期主要心脏并发症的发生率。

结果

在识别出的4625例患者中,大多数因恶性疾病接受手术(78%),且采用开放手术(70%)。在ThRCRI危险因素中,9%的患者有缺血性心脏病,7%有脑血管疾病,2%有肾脏合并症,6%接受了全肺切除术。所有患者心脏并发症的发生率为2%。A、B、C和D风险类别中心脏并发症的发生率分别为1%、3%、9%和4%(p<0.01)。

结论

利用大型多机构数据集,ThRCRI可以区分肺切除术后心脏并发症风险较高的患者(C类和D类),并且可以成为一种有用的术前工具。ThRCRI可能有助于识别那些将从额外心脏评估中获益的患者。

相似文献

1
Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection.肺切除术后验证修订的胸段心脏风险指数
Ann Thorac Surg. 2017 Aug;104(2):389-394. doi: 10.1016/j.athoracsur.2017.02.006. Epub 2017 May 9.
2
External validation of the recalibrated thoracic revised cardiac risk index for predicting the risk of major cardiac complications after lung resection.校正后的胸外科修订心脏风险指数在预测肺切除术后主要心脏并发症风险中的外部验证。
Ann Thorac Surg. 2011 Aug;92(2):445-8. doi: 10.1016/j.athoracsur.2011.03.095. Epub 2011 Jun 24.
3
Validation of a modified scoring system for cardiovascular risk associated with major lung resection.改良的主要肺切除相关心血管风险评分系统的验证。
Eur J Cardiothorac Surg. 2012 Mar;41(3):598-602. doi: 10.1093/ejcts/ezr081. Epub 2011 Dec 1.
4
Prediction of major cardiovascular events after lung resection using a modified scoring system.改良评分系统预测肺切除术后主要心血管事件。
Ann Thorac Surg. 2014 Apr;97(4):1135-40. doi: 10.1016/j.athoracsur.2013.12.032. Epub 2014 Feb 22.
5
Does the revised cardiac risk index predict cardiac complications following elective lung resection?修订后的心脏风险指数能否预测择期肺切除术后的心脏并发症?
J Cardiothorac Surg. 2013 Dec 1;8:220. doi: 10.1186/1749-8090-8-220.
6
Thoracic Revised Cardiac Risk Index Is Associated With Prognosis After Resection for Stage I Lung Cancer.胸段修订心脏风险指数与Ⅰ期肺癌切除术后预后相关。
Ann Thorac Surg. 2015 Jul;100(1):195-200. doi: 10.1016/j.athoracsur.2015.03.103. Epub 2015 May 21.
7
B-type natriuretic Peptide as a predictor of postoperative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer.B 型利钠肽作为预测老年肺癌患者行肺切除术后心肺并发症的指标。
Ann Thorac Surg. 2011 Sep;92(3):1051-5. doi: 10.1016/j.athoracsur.2011.03.085.
8
Index of prolonged air leak score validation in case of video-assisted thoracoscopic surgery anatomical lung resection: results of a nationwide study based on the French national thoracic database, EPITHOR.电视辅助胸腔镜手术解剖性肺切除术中持续漏气评分验证指数:基于法国国家胸部数据库EPITHOR的全国性研究结果
Eur J Cardiothorac Surg. 2015 Oct;48(4):608-11. doi: 10.1093/ejcts/ezu505. Epub 2015 Jan 5.
9
Recalibration of the revised cardiac risk index in lung resection candidates.肺切除候选者中修订后的心脏风险指数的再校准。
Ann Thorac Surg. 2010 Jul;90(1):199-203. doi: 10.1016/j.athoracsur.2010.03.042.
10
Effect of postoperative haemoglobin variation on major cardiopulmonary complications in high cardiac risk patients undergoing anatomical lung resections.术后血红蛋白变化对接受解剖性肺切除的高心脏风险患者主要心肺并发症的影响。
Interact Cardiovasc Thorac Surg. 2019 Dec 1;29(6):883-889. doi: 10.1093/icvts/ivz199.

引用本文的文献

1
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives.可切除非小细胞肺癌患者新兴的精准新辅助全身治疗:现状与展望
Biomark Res. 2023 Jan 18;11(1):7. doi: 10.1186/s40364-022-00444-7.
2
Risk Stratification for Lung Cancer Patients.肺癌患者的风险分层
Cureus. 2022 Oct 24;14(10):e30643. doi: 10.7759/cureus.30643. eCollection 2022 Oct.
3
Frailty Is Associated With Adverse Postoperative Outcomes After Lung Cancer Resection.衰弱与肺癌切除术后不良预后相关。
JTO Clin Res Rep. 2022 Sep 29;3(11):100414. doi: 10.1016/j.jtocrr.2022.100414. eCollection 2022 Nov.
4
How can we minimize the risks by optimizing patient's condition shortly before thoracic surgery?我们如何通过在胸外科手术前不久优化患者状况来将风险降至最低?
Saudi J Anaesth. 2021 Jul-Sep;15(3):264-271. doi: 10.4103/sja.sja_1098_20. Epub 2021 Jun 19.
5
Should we screen patients for carotid artery disease before lung cancer resection?我们是否应该在肺癌切除术前对患者进行颈动脉疾病筛查?
J Thorac Dis. 2020 Nov;12(11):6743-6751. doi: 10.21037/jtd-20-1117.
6
Cardiopulmonary Testing Before Lung Resection: What Are Thoracic Surgeons Doing?肺切除术前心肺检测:胸外科医生在做什么?
Ann Thorac Surg. 2019 Oct;108(4):1006-1012. doi: 10.1016/j.athoracsur.2019.04.057. Epub 2019 Jun 7.
7
Patient and procedural features predicting early and mid-term outcome after radical surgery for non-small cell lung cancer.预测非小细胞肺癌根治性手术后早期和中期预后的患者及手术特征
J Thorac Dis. 2018 Nov;10(11):6020-6029. doi: 10.21037/jtd.2018.10.36.
8
Impact of previous head and neck cancer on postoperative complications after surgical resection for lung cancer: a case-control study.既往头颈癌对肺癌手术切除术后并发症的影响:一项病例对照研究。
J Thorac Dis. 2018 Jul;10(7):3948-3956. doi: 10.21037/jtd.2018.06.77.